Navigation Links
Ohio Supreme Court Supports Regulation of Dangerous Abortion Drug
Date:7/6/2009

CHICAGO, July 2 /PRNewswire-USNewswire/ -- Pro-life forces won an important battle yesterday when the Ohio Supreme Court ruled that abortion providers, under a state law regulating the administration of RU-486, must strictly comply with the FDA-approved protocol for the dangerous abortion drug.

The ruling came in Rogers v. Planned Parenthood, a challenge by Planned Parenthood to a 2004 state law requiring that those administering RU-486 comply with the FDA-approved treatment protocol for the "abortion pill" and, consistent with the drug's safety and efficacy data, restrict its use to pregnancies at or under 49 days gestation. In short, the law simply requires abortionists to abide by the rules approved by the FDA when it first made RU-486 available in the United States in September 2000.

Dr. Charmaine Yoest, AUL President & CEO said, "We applaud the Ohio Supreme Court for cutting through Planned Parenthood's self-serving rhetoric that it did not need to follow the protocol tested and approved by the FDA when administering RU-486. For far too long, Planned Parenthood and its enablers have thought themselves above the law. Today the Ohio Supreme Court put a decisive end to that."

Americans United for Life (AUL) filed an amicus brief in the case on behalf of several U.S. Representatives supporting the State and the law. AUL's amicus brief, filed on behalf of House Minority Leader John Boehner (Ohio) and nine U.S. Representatives -- Roscoe Bartlett (Md.), Dan Burton (Ind.), Steve Chabot (Ohio), Trent Franks (Ariz.), Jim Jordan (Ohio), Robert E. Latta (Ohio), Joseph R. Pitts (Pa.), Jean Schmidt (Ohio), and Chris Smith (N.J.) -- is available at

http://www.aul.org/xm_client/client_documents/briefs/Rogers_v_PlannedParenthood.pdf.

AUL Staff Counsel Mailee Smith said, "The fact that Planned Parenthood readily admits to routinely disregarding the FDA-approved protocol and actually argued it was entitled to dispense RU-486 in an untested and dangerous manner is appalling. It is further confirmation that Planned Parenthood is not the protector of women's health and welfare it holds itself out to be."

Planned Parenthood argued the law was unconstitutional and that its requirements were unclear. The State of Ohio and AUL argued that the Ohio law is definitive in its requirement that abortionists can use the RU-486 drug regimen only in the way in which it was tested and approved by the FDA, as is clearly laid out in the manufacturer's label that accompanies the drug.

The case will now return to the Sixth Circuit Court of Appeals for a decision of whether the statute, as interpreted by the Ohio Supreme Court, is constitutional.

About Americans United for Life

Americans United for Life (AUL) is a nonprofit, public-interest law and policy organization whose vision is a nation in which everyone is welcomed in life and protected in law. The first national pro-life organization in America, AUL has been committed to defending human life through vigorous judicial, legislative, and educational efforts at both the federal and state levels since 1971. The Wall Street Journal has profiled AUL, and PBS' Frontline program chronicled AUL's successful efforts in Mississippi.


'/>"/>
SOURCE Americans United for Life
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
3. ALLs Judie Brown: Supreme Court is Wrong on Contraception Ruling
4. Autism Speaks Applauds Supreme Court Decision Upholding Families Right to Challenge IEPs Without First Trying Out School District Proposed Placement
5. California Veterinary Medical Association Reacts to Supreme Court Decision
6. Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc.
7. Supreme Court Hears Case on Federal Pre-emption of Safety Standards for Medical Technologies (Riegel v. Medtronic, Inc.)
8. Michigan Resident, Kimberly Kents Drug Product Liability Case Will Be Argued in the United States Supreme Court on February 25, 2008
9. Surprise U.S. Supreme Court Decision Helps Michigan Citizens
10. AARP Deeply Disappointed by Supreme Court Decision on Retiree Health Care Benefits
11. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... ... an agile ecosystem and domain expertise for sponsors and CROs to speed ... trial supply management (RTSM) software platform. Bioclinica AGILE RTSM provides ...
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop Inc. , ... . This new addition to the Mirroring360 product family combines device screen mirroring ... Mirroring360 Pro enables educators, business professionals and individuals to stream or mirror app ...
(Date:4/25/2017)... NY (PRWEB) , ... April 25, 2017 , ... A ... stress at work can also decrease overall productivity and performance in the workplace. The ... employees. , During the last few weeks of April, Clearview Resolution Services will be ...
(Date:4/25/2017)... ... ... The doctors at Wall Centre Dental are now expanding their practice by accepting ... receive dental care. The doctors offer three treatment options to put victims of ... at their dental office in Vancouver. Wall Centre Dental is currently welcoming even patients ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... 2017 Research and Markets has announced the ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ... ... will rise from USD 20 Billion in 2015 to around USD ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ...
Breaking Medicine Technology: